Biomarker Relatability in the International Severe Asthma Registry

E. Denton, M. Hew, T.N. Tran, G. Canonica, A. Menzies-Gow, M. FitzGerald, M. Sadatsafavi, L. Perez de Llano, G. Christoff, A. Quinton, C. Rhee, G. Brusselle, C. Ulrik, N. Lugogo, I. Chaudry, L. Bulathsinhala, R. Murray, V. A Carter, D. Price

Research output: Contribution to journalAbstractpeer-review

Abstract

Rationale: Inflammatory biomarkers are useful to phenotype patients with severe asthma and guide targeted therapies. Little is known about the overlap and relatability of positive biomarkers in severe asthma.
Original languageEnglish
Article numberA4535
Number of pages2
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume201
Issue numberC21
DOIs
Publication statusPublished - 2020

Bibliographical note

This abstract is funded by: ISAR is conducted by Optimum Patient Care Global Limited, and co-funded by OPC Global and AstraZeneca.

Fingerprint

Dive into the research topics of 'Biomarker Relatability in the International Severe Asthma Registry'. Together they form a unique fingerprint.

Cite this